Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Hypertension × aliskiren × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 1 Hypertension 1 Essential Hypertension 1

Interventions

relacorilant 5 Hydrochlorothiazide 2 Amlodipine 2 sacubitril and valsartan sodium hydrate drug combination 1 pembrolizumab 1 fimasartan 1 aliskiren 1 Osilodrostat 1 Enalapril 1 Amlodipine, Valsartan Drug Combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01151410 2016-03-07

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Novartis

Phase 3 Completed

208 enrolled 10 charts

Essential Hypertension, Hypertension, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡